Insider · CIK 0001780030
Brian C Stephenson
cfoofficer
Files at BBIO (BridgeBio Pharma, Inc.). First filing Nov 20, 2024, latest Feb 27, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $3.0M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BBIO: BridgeBio Pharma, Inc.
BBIOOct 9, 2026 · close 65.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | BridgeBio Pharma, Inc. | $282k 8,500 shares | -8% | - | |
| 13Weak | BridgeBio Pharma, Inc. | $150k 4,148 shares | -4% | - | |
| 37Weak | BridgeBio Pharma, Inc. | $2.5M 68,000 shares | -42% | - | |
| 20Weak | BridgeBio Pharma, Inc. | $93k 4,156 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Feb 25, 2025 | BBIO BRIDGEBIO PHARMA INC | 34,000 0.02% of outstanding | $1.2M | Feb 25, 2025 | $2.6M |
| Feb 19, 2025 | BBIO BRIDGEBIO PHARMA INC | 4,148 0.00% of outstanding | $147k | Feb 19, 2025 | $2.5M |
| Jan 28, 2025 | BBIO BridgeBio Pharma, Inc. | 68,000 0.04% of outstanding | $2.5M | Jan 28, 2025 | $93k |
| Nov 19, 2024 | BBIO BRIDGEBIO PHARMA INC | 4,156 0.00% of outstanding | $93k | Nov 19, 2024 | none |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 25, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +8,500 | $17.00 | $145k | 110,964 | Feb 27, 2025 |
| Feb 25, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -8,400 | $33.18 | $279k | 102,564 | Feb 27, 2025 |
| Feb 25, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -100 | $34.18 | $3,418 | 102,464 | Feb 27, 2025 |
| Feb 25, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -8,500 | $0.00 | $0 | 440,170 | Feb 27, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +25,798 | - | - | 119,714 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock10b5-1 | -13,102 | $34.90 | $457k | 106,612 | Feb 19, 2025 |
| Feb 19, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -4,148 | $36.16 | $150k | 102,464 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -779 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -946 | $0.00 | $0 | 2,840 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -17,368 | $0.00 | $0 | 138,947 | Feb 19, 2025 |
| Feb 16, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative10b5-1 | -6,705 | $0.00 | $0 | 80,459 | Feb 19, 2025 |
| Jan 28, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock10b5-1 | +68,000 | $17.00 | $1.2M | 161,758 | Jan 30, 2025 |
| Jan 28, 2025 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -68,000 | $36.29 | $2.5M | 93,758 | Jan 30, 2025 |
| Jan 28, 2025 | BBIO BridgeBio Pharma, Inc. | MOption exercise Stock Option (right to buy)derivative10b5-1 | -68,000 | $0.00 | $0 | 448,670 | Jan 30, 2025 |
| Dec 10, 2024 | BBIO BridgeBio Pharma, Inc. | AGrant or award Restricted Stock Unitsderivative | +42,683 | $0.00 | $0 | 42,683 | Dec 12, 2024 |
| Nov 19, 2024 | BBIO BridgeBio Pharma, Inc. | SOpen-market sale Common Stock10b5-1 | -4,156 | $22.41 | $93k | 93,758 | Nov 20, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Common Stock | +25,799 | - | - | 110,991 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | FTax withholding Common Stock | -13,077 | $23.72 | $310k | 97,914 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -778 | $0.00 | $0 | 779 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -947 | $0.00 | $0 | 3,786 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -17,369 | $0.00 | $0 | 156,315 | Nov 19, 2024 |
| Nov 16, 2024 | BBIO BridgeBio Pharma, Inc. | MOption exercise Restricted Stock Unitsderivative | -6,705 | $0.00 | $0 | 87,164 | Nov 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.